pubmed· e01.org

PubMed · PMID 33149122

Discovery of driver non-coding splice-site-creating mutations in cancer.

PMID 33149122Journal Nature communicationsYear 2020Authors 16DOI 10.1038/s41467-020-19307-6

  • Source PubMed
  • Journal Nature communications
  • Year 2020
  • Authors Song Cao; Daniel Cui Zhou; Clara Oh; Reyka G Jayasinghe; Yanyan Zhao; Christopher J Yoon; Matthew A Wyczalkowski; Matthew H Bailey; Terrence Tsou; Qingsong Gao; Andrew Malone; Sheila Reynolds; Ilya Shmulevich; Michael C Wendl; Feng Chen; Li Ding
  • Licence NLM/PubMed terms

Abstract

Non-coding mutations can create splice sites, however the true extent of how such somatic non-coding mutations affect RNA splicing are largely unexplored. Here we use the MiSplice pipeline to analyze 783 cancer cases with WGS data and 9494 cases with WES data, discovering 562 non-coding mutations that lead to splicing alterations. Notably, most of these mutations create new exons. Introns associated with new exon creation are significantly larger than the genome-wide average intron size.

We find that some mutation-induced splicing alterations are located in genes important in tumorigenesis (ATRX, BCOR, CDKN2B, MAP3K1, MAP3K4, MDM2, SMAD4, STK11, TP53 etc.), often leading to truncated proteins and affecting gene expression. The pattern emerging from these exon-creating mutations suggests that splice sites created by non-coding mutations interact with pre-existing potential splice sites that originally lacked a suitable splicing pair to induce new exon formation.

Our study suggests the importance of investigating biological and clinical consequences of noncoding splice-inducing mutations that were previously neglected by conventional annotation pipelines. MiSplice will be useful for automatically annotating the splicing impact of coding and non-coding mutations in future large-scale analyses.

Record details

PMID33149122
PMCIDnot held
DOI10.1038/s41467-020-19307-6
JournalNature communications
Year2020
AuthorsSong Cao; Daniel Cui Zhou; Clara Oh; Reyka G Jayasinghe; Yanyan Zhao; Christopher J Yoon; Matthew A Wyczalkowski; Matthew H Bailey; Terrence Tsou; Qingsong Gao; Andrew Malone; Sheila Reynolds; Ilya Shmulevich; Michael C Wendl; Feng Chen; Li Ding
Licencenot stated
MeSHAMP-Activated Protein Kinase Kinases; Cyclin-Dependent Kinase Inhibitor p15; Databases, Genetic; Exons; Gene Expression Regulation, Neoplastic; Humans; Introns; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinase 4; Mutation; Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; RNA Precursors; RNA Splice Sites; RNA Splicing; RNA, Untranslated; RNA-Seq; Repressor Proteins; Smad4 Protein; Tumor Suppressor Protein p53; Exome Sequencing; X-linked Nuclear Protein

Source record

Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.

Source
PubMed / NLM
PMID
33149122
Rendered
2026-11-22
Completeness
abstract and citation fields